10.1016/S0969-8051(98)00115-2 Nuclear Med
The dependent variable, retained gastric contents on EGD, was measured on a dichotomous scale that was mutually exclusive and exhaustive
anyone promising guaranteed outcomes should be treated with skepticism
Consequently, BPC 157 may have beneficial activity with the same dose range, and same equipotent routes of application, regardless of injury tested (Sikiric et al., 1993
GI side effects in clinical trials typically resolved within 23 weeks, but if symptoms persist beyond four weeks at a reduced dose, discontinuation is warranted
Theyve been used exclusively for weight management for over 10 years